Trevena (TRVN) Expected to Announce Quarterly Earnings on Monday

Trevena (NASDAQ:TRVN) is expected to be posting its quarterly earnings results before the market opens on Monday, March 31st. Analysts expect Trevena to post earnings of ($7.37) per share for the quarter.

Trevena Price Performance

Shares of NASDAQ TRVN opened at $1.25 on Friday. The business has a fifty day moving average price of $1.60 and a 200 day moving average price of $2.11. Trevena has a 1-year low of $1.13 and a 1-year high of $11.50. The stock has a market capitalization of $1.08 million, a P/E ratio of -0.03 and a beta of 1.05.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Trevena in a research note on Thursday. They issued a “sell” rating for the company.

Trevena Company Profile

Trevena, Inc, a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain.